Due to health issues, this site is no longer maintained and will be shut down shortly.

GF:BAYN Bayer Aktiengesellschaft

Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, Crop Science, Animal Health, and Covestro segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents. The Consumer Health segment provides nonprescription over-the-counter products in the dermatology, nutritional supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care, and sun protection categories. The Crop Science segment offers products in the areas of seeds and plant traits, crop protection, and nonagricultural pest control. The Animal Health segment provides prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; and raw materials for coatings, adhesives, and sealants; and by-products of polyether production and of chlorine production and use. The company has strategic partnerships with Broad Institute and German Cancer Research Center, as well as strategic research alliance with University of Oxford; and a multi-target endometriosis alliance with Evotec AG. It also has a strategic alliance with Rothamsted Research; and a research agreement with Vanderbilt University Medical Center to develop therapies for kidney diseases. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

This company cross-lists their shares on a U.S. stock exchange. See the related U.S. symbol BAYZF.

This company has ADRs that trade in the U.S. as the symbol BAYRY.This company has cross-listed shares that trade in the U.S. as the symbol BAYZF.

56.05 EUR
As of 03/23/2023


Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Developed markets ex-US
GICS sector:  Health Care
Industry:  
Index country:  Germany
Country of incorporation:  Germany
IPO date:  09/21/2009
Stock exchange:    Frankfurt Stock Exchange
Exchange country:   Germany
Market cap:   0 EUR
Current dividend yield:   0.00%
Sedol:      5069211

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy